Dr. Viveka Kumar, Senior Director - Cath Lab, Max Super Speciality Hospital, Saket, will talk about the role of ticagrelor in acute MI, in this video. Ticagrelor has revolutionized the treatment of acute MI. it has also shown to reduce mortality in all situations. He will also explain that the only condition where the ticagrelor treatment is not used is when the patient is undergoing thrombolytic therapy.
Dr. Viveka Kumar is a Senior Consultant Interventional Cardiologist and Director of the Cath Lab at Max Super Speciality Hospital in Saket, New Delhi. He completed his MBBS and MD (Medicine) from IMS (BHU), Varanasi and later obtained the DM (Cardiology) postdoc, superspeciality degree through GSVM Medical College, Kanpur. Has extensive experience in the field of Cardiac interventions and Electrophysiology. Specializes in complex angioplasties including multivessel, bifurication and left main angioplasties with Rota Ablation, FFR, IVUS, IABP, IMPELLA devices. Has done more than 7500 angioplasties and 2500 balloon valvotomies with good outcomes.